BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28938621)

  • 21. Immunoglobulin A Deposits In Renal Allografts: A Prospective Longitudinal Single-Center Study.
    Ganesh K; Jayaram JK; Thomas RM; Abraham TT; Kumar JS; Simon SS; Abraham MA
    Transplant Proc; 2024; 56(1):97-104. PubMed ID: 38216361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous cadaver pancreas living-donor kidney transplantation: a new approach for the type 1 diabetic uremic patient.
    Farney AC; Cho E; Schweitzer EJ; Dunkin B; Philosophe B; Colonna J; Jacobs S; Jarrell B; Flowers JL; Bartlett ST
    Ann Surg; 2000 Nov; 232(5):696-703. PubMed ID: 11066142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of patients at risk for renal impairment after living donor kidney transplantation.
    Kaltenborn A; Nolte A; Schwager Y; Littbarski SA; Emmanouilidis N; Arelin V; Klempnauer J; Schrem H
    Langenbecks Arch Surg; 2016 Dec; 401(8):1219-1229. PubMed ID: 27502290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ; Kwak JY; Kang CM
    Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of 15 cases of renal transplantation with pre
    Fan H; Liu J; Sun J; Wang J; Pang X; Shang W; Feng G; Li J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1583-1591. PubMed ID: 38432887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation.
    Halimi JM; Laouad I; Buchler M; Al-Najjar A; Chatelet V; Houssaini TS; Nivet H; Lebranchu Y
    Am J Transplant; 2005 Sep; 5(9):2281-8. PubMed ID: 16095510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney Transplantation From Old Deceased Donors: Impact of Uric Acid Level-A Quarter-Century of Experience in One Transplant Center.
    Magott-Procelewska M; Madziarska K; Boratynska M; Chudoba P; Lepiesza A; Mazanowska O; Zmonarski S; Madziarski M; Hap K; Klinger M
    Transplant Proc; 2018; 50(6):1701-1704. PubMed ID: 30056885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimal proteinuria one year after transplant is a risk factor for graft survival in kidney transplantation.
    Kang NR; Lee JE; Huh W; Kim SJ; Kim YG; Kim DJ; Oh HY
    J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S129-34. PubMed ID: 19194542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Renal Growth, Proteinuria and Graft Survival between Recipients of Pediatric and Adult Cadaveric Kidney Transplants.
    Basiri A; Zare S; Simforoosh N; Tabibi A; Shakibi MH
    Int J Organ Transplant Med; 2017; 8(2):97-103. PubMed ID: 28828169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of kidney transplantation from older living donors to older recipients.
    Gill J; Bunnapradist S; Danovitch GM; Gjertson D; Gill JS; Cecka M
    Am J Kidney Dis; 2008 Sep; 52(3):541-52. PubMed ID: 18653267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-Varying Determinants of Graft Failure in Pediatric Kidney Transplantation in Europe.
    Coens F; Knops N; Tieken I; Vogelaar S; Bender A; Kim JJ; Krupka K; Pape L; Raes A; Tönshoff B; Prytula A;
    Clin J Am Soc Nephrol; 2024 Mar; 19(3):345-354. PubMed ID: 38030557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decade of experience with renal transplantation in African-Americans.
    Foster CE; Philosophe B; Schweitzer EJ; Colonna JO; Farney AC; Jarrell B; Anderson L; Bartlett ST
    Ann Surg; 2002 Dec; 236(6):794-804; discussion 804-805. PubMed ID: 12454518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteinuria after renal transplantation affects not only graft survival but also patient survival.
    Roodnat JI; Mulder PG; Rischen-Vos J; van Riemsdijk IC; van Gelder T; Zietse R; IJzermans JN; Weimar W
    Transplantation; 2001 Aug; 72(3):438-44. PubMed ID: 11502973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of deceased donor proteinuria for kidney transplantation: A comprehensive national cohort study.
    Kuhn C; Born A; Karolin A; Lang B; Binet I; Golshayan D; Haidar F; Müller TF; Schaub S; Immer F; Koller M; Sidler D;
    Clin Transplant; 2022 Apr; 36(4):e14574. PubMed ID: 35124857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early assessment of renal resistance index after kidney transplant can help predict long-term renal function.
    Saracino A; Santarsia G; Latorraca A; Gaudiano V
    Nephrol Dial Transplant; 2006 Oct; 21(10):2916-20. PubMed ID: 16891640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The OPTN/UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.